ExodusPoint Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | – | Sell |
-26,261
| Closed | -$792K | – | 1622 |
|
2025
Q1 | $792K | Buy |
+26,261
| New | +$792K | 0.01% | 929 |
|
2024
Q3 | – | Sell |
-209,194
| Closed | -$9.97M | – | 1697 |
|
2024
Q2 | $9.97M | Sell |
209,194
-6,699
| -3% | -$319K | 0.07% | 222 |
|
2024
Q1 | $9.36M | Buy |
215,893
+192,409
| +819% | +$8.34M | 0.07% | 184 |
|
2023
Q4 | $1.19M | Buy |
+23,484
| New | +$1.19M | 0.01% | 692 |
|
2023
Q2 | – | Sell |
-265,330
| Closed | -$9.48M | – | 1944 |
|
2023
Q1 | $9.48M | Sell |
265,330
-39,060
| -13% | -$1.4M | 0.08% | 231 |
|
2022
Q4 | $11.5M | Buy |
304,390
+297,973
| +4,643% | +$11.3M | 0.17% | 132 |
|
2022
Q3 | $284K | Sell |
6,417
-31,173
| -83% | -$1.38M | ﹤0.01% | 1506 |
|
2022
Q2 | $1.39M | Buy |
+37,590
| New | +$1.39M | 0.02% | 896 |
|
2022
Q1 | – | Sell |
-19,788
| Closed | -$602K | – | 2345 |
|
2021
Q4 | $602K | Buy |
19,788
+11,615
| +142% | +$353K | 0.01% | 1267 |
|
2021
Q3 | $274K | Buy |
+8,173
| New | +$274K | ﹤0.01% | 1605 |
|
2020
Q4 | – | Sell |
-26,507
| Closed | -$1.26M | – | 2071 |
|
2020
Q3 | $1.26M | Buy |
+26,507
| New | +$1.26M | 0.03% | 543 |
|
2020
Q2 | – | Sell |
-5,934
| Closed | -$281K | – | 1856 |
|
2020
Q1 | $281K | Buy |
5,934
+1,280
| +28% | +$60.6K | 0.02% | 631 |
|
2019
Q4 | $281K | Buy |
+4,654
| New | +$281K | 0.01% | 1118 |
|
2019
Q2 | – | Sell |
-63,522
| Closed | -$5.16M | – | 1191 |
|
2019
Q1 | $5.16M | Buy |
63,522
+58,022
| +1,055% | +$4.71M | 0.38% | 41 |
|
2018
Q4 | $297K | Buy |
+5,500
| New | +$297K | 0.02% | 191 |
|